National Institute on Drug Abuse; Notice of Closed Meeting

Federal Register, Volume 83 Issue 90 (Wednesday, May 9, 2018)

Federal Register Volume 83, Number 90 (Wednesday, May 9, 2018)

Notices

Page 21301

From the Federal Register Online via the Government Publishing Office www.gpo.gov

FR Doc No: 2018-09901

Page 21301

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

National Institute on Drug Abuse; Notice of Closed Meeting

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; Rodent Testing to Identify Pharmacotherapies for Substance Dependence (8936).

Date: May 24, 2018.

Time: 10:00 a.m. to 12:00 p.m.

Agenda: To review and evaluate contract proposals.

Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call).

Contact Person: Lyle Furr, Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 4227, MSC 9550, 6001 Executive Boulevard, Bethesda, MD 20892-

9550, (301) 827-5702, lf33c.nih.gov.

(Catalogue of Federal Domestic Assistance Program No.: 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS)

Dated: May 4, 2018.

Natasha M. Copeland,

Program Analyst, Office of Federal Advisory Committee Policy.

FR Doc. 2018-09901 Filed 5-8-18; 8:45 am

BILLING CODE 4140-01-P